Mucormycosis associated with COVID‐19 in two kidney transplant patients
Carolt Arana, Rafael Ramírez, Marc Xipell, Joaquim Casals, Asunción Moreno, Sabina Herrera, Marta Bodro, Frederic Cofán, Fritz Diekmann, Núria Esforzado
Abstract
Coronavirus disease 2019 (COVID-19) predisposes patients to bacterial and fungal superinfections due to the impairment of the immunological system. Among the associated opportunistic fungal infections, mucormycosis is one of the least frequent but with the highest mortality. We describe two cases of mucormycosis in two kidney transplant recipients, while they were hospitalized for SARS-CoV-2 pneumonia, with rhinosinusal and musculoskeletal involvement, respectively.
Topics & Concepts
MucormycosisMedicinePneumoniaCoronavirus disease 2019 (COVID-19)Kidney transplantSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Opportunistic infectionCoronavirusKidney transplantationDiseaseKidneyIntensive care medicineImmunologyInternal medicineInfectious disease (medical specialty)PathologyHuman immunodeficiency virus (HIV)Viral diseaseAntifungal resistance and susceptibilityAntibiotic Use and ResistanceIntensive Care Unit Cognitive Disorders